These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9933479)

  • 1. A trans-acting enhancer modulates estrogen-mediated transcription of reporter genes in osteoblasts.
    Sasaki-Iwaoka H; Maruyama K; Endoh H; Komori T; Kato S; Kawashima H
    J Bone Miner Res; 1999 Feb; 14(2):248-55. PubMed ID: 9933479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cbfa1 isoform overexpression upregulates osteocalcin gene expression in non-osteoblastic and pre-osteoblastic cells.
    Xiao ZS; Hinson TK; Quarles LD
    J Cell Biochem; 1999 Sep; 74(4):596-605. PubMed ID: 10440929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the human oestrogen receptor-alpha gene is regulated by promoter F in MG-63 osteoblastic cells.
    Lambertini E; Penolazzi L; Giordano S; Del Senno L; Piva R
    Biochem J; 2003 Jun; 372(Pt 3):831-9. PubMed ID: 12659635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tamoxifen agonism and estrogen antagonism of c-fos gene promoter activity through non-consensus-responsive elements in MC3T3-E1 osteoblasts.
    Ishibashi O; Yamagishi T; Hanada K; Kawashima H
    Biochem Biophys Res Commun; 2001 Dec; 289(3):705-11. PubMed ID: 11726205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation.
    Lee MH; Javed A; Kim HJ; Shin HI; Gutierrez S; Choi JY; Rosen V; Stein JL; van Wijnen AJ; Stein GS; Lian JB; Ryoo HM
    J Cell Biochem; 1999 Apr; 73(1):114-25. PubMed ID: 10088730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in Runx2/Cbfa1 expression and activity during osteoblastic differentiation of human bone marrow stromal cells.
    Shui C; Spelsberg TC; Riggs BL; Khosla S
    J Bone Miner Res; 2003 Feb; 18(2):213-21. PubMed ID: 12568398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential use of an estrogen-glucocorticoid receptor chimera as a drug screen for tissue selective estrogenic activity.
    Maru BS; Tobias JH; Rivers C; Caunt CJ; Norman MR; McArdle CA
    Bone; 2009 Jan; 44(1):102-12. PubMed ID: 18976723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting estrogen responsive elements (EREs): design of potent transactivators for ERE-containing genes.
    Huang J; Li X; Yi P; Hilf R; Bambara RA; Muyan M
    Mol Cell Endocrinol; 2004 Apr; 218(1-2):65-78. PubMed ID: 15130512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen induces the expression of maspin through estrogen receptor-alpha.
    Liu Z; Shi HY; Nawaz Z; Zhang M
    Cancer Lett; 2004 Jun; 209(1):55-65. PubMed ID: 15145521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor.
    Hyder SM; Nawaz Z; Chiappetta C; Stancel GM
    Cancer Res; 2000 Jun; 60(12):3183-90. PubMed ID: 10866309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional regulation of the human Runx2/Cbfa1 gene promoter by bone morphogenetic protein-7.
    Tou L; Quibria N; Alexander JM
    Mol Cell Endocrinol; 2003 Jul; 205(1-2):121-9. PubMed ID: 12890574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway.
    Yang J; Fizazi K; Peleg S; Sikes CR; Raymond AK; Jamal N; Hu M; Olive M; Martinez LA; Wood CG; Logothetis CJ; Karsenty G; Navone NM
    Cancer Res; 2001 Jul; 61(14):5652-9. PubMed ID: 11454720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen receptor-beta modulates synthesis of bone matrix proteins in human osteoblast-like MG63 cells.
    Cao L; Bu R; Oakley JI; Kalla SE; Blair HC
    J Cell Biochem; 2003 May; 89(1):152-64. PubMed ID: 12682916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of the human progesterone receptor gene through an estrogen response element half site and Sp1 sites.
    Petz LN; Ziegler YS; Schultz JR; Kim H; Kemper JK; Nardulli AM
    J Steroid Biochem Mol Biol; 2004 Feb; 88(2):113-22. PubMed ID: 15084343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cbfa1 contributes to the osteoblast-specific expression of type I collagen genes.
    Kern B; Shen J; Starbuck M; Karsenty G
    J Biol Chem; 2001 Mar; 276(10):7101-7. PubMed ID: 11106645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of human cbfa1 gene transcription in osteoblasts by selective estrogen receptor modulators (SERMs).
    Tou L; Quibria N; Alexander JM
    Mol Cell Endocrinol; 2001 Oct; 183(1-2):71-9. PubMed ID: 11604227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor beta activates the human retinoic acid receptor alpha-1 promoter in response to tamoxifen and other estrogen receptor antagonists, but not in response to estrogen.
    Zou A; Marschke KB; Arnold KE; Berger EM; Fitzgerald P; Mais DE; Allegretto EA
    Mol Endocrinol; 1999 Mar; 13(3):418-30. PubMed ID: 10076999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4-hydroxytamoxifen trans-represses nuclear factor-kappa B activity in human osteoblastic U2-OS cells through estrogen receptor (ER)alpha, and not through ER beta.
    Quaedackers ME; Van Den Brink CE; Wissink S; Schreurs RH; Gustafsson JA; Van Der Saag PT; Van Der Burg BB
    Endocrinology; 2001 Mar; 142(3):1156-66. PubMed ID: 11181531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The osteoblast-specific transcription factor Cbfa1 contributes to the expression of osteoprotegerin, a potent inhibitor of osteoclast differentiation and function.
    Thirunavukkarasu K; Halladay DL; Miles RR; Yang X; Galvin RJ; Chandrasekhar S; Martin TJ; Onyia JE
    J Biol Chem; 2000 Aug; 275(33):25163-72. PubMed ID: 10833509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.